DCGI approves anti Covid-19 drug developed by DRDO for emergency use
NEW DELHI: An anti-COVID-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG) has been developed by Institute of Nuclear Medicine and...
DCGI
Covid-19 infection in adults: Zydus receives emergency use approval from DCGI
NEW DELHI: Zydus Cadila today announced that the company has received Restricted Emergency Use Approval from the Drug Controller General...
DCGI extends shelf life of Covishield from 6 to 9 months
NEW DELHI: India's drug regulator DCGI has extended the shelf life of Covishield, the Oxford-AstraZeneca COVID-19 vaccine, from six to...
